BL-1060

N/A

Report date: 2022/08/24 20:00:31

Base Information

Drug NameBL-1060
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCholesterol inhibitors
TargetsCholesterol
Therapy Area/IndicationsMetabolic Dysfunction-Associated Steatotic Liver DiseaseLiver Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGalmed International Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGalmed International Ltd
Active IndicationsN/A
Inactive IndicationsMetabolic Dysfunction-Associated Steatotic Liver DiseaseLiver Diseases

Other Information

ATC CodeN/A
Related LinksN/A